Undisclosed CAR-T / Seattle Children’s Therapeutics - LARVOL DELTA

1st CAR T-cell trial in children with lupus in US gets FDA go-ahead (Lupus News Today) - "Seattle Children’s has been cleared by the U.S. Food and Drug Administration (FDA) to start the nation’s first clinical trial testing CAR T-cell therapy in children with systemic lupus erythematosus, the most common form of lupus. The trial, Reversing Autoimmunity through Cell Therapy (REACT-01), is targeted for a summer launch."

New trial • Lupus • Systemic Lupus Erythematosus